AMRX logo

Amneal Pharmaceuticals (AMRX) Accounts payable

annual accounts payable:

$258.69M+$115.12M(+80.18%)
December 31, 2024

Summary

  • As of today (May 29, 2025), AMRX annual accounts payable is $258.69 million, with the most recent change of +$115.12 million (+80.18%) on December 31, 2024.
  • During the last 3 years, AMRX annual accounts payable has risen by +$127.61 million (+97.35%).
  • AMRX annual accounts payable is now at all-time high.

Performance

AMRX Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXbalance sheet metrics

quarterly accounts payable:

$192.53M-$66.16M(-25.57%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AMRX quarterly accounts payable is $192.53 million, with the most recent change of -$66.16 million (-25.57%) on March 31, 2025.
  • Over the past year, AMRX quarterly accounts payable has increased by +$17.21 million (+9.81%).
  • AMRX quarterly accounts payable is now -68.62% below its all-time high of $613.62 million, reached on September 30, 2020.

Performance

AMRX quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

AMRX Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+80.2%+9.8%
3 y3 years+97.3%-64.3%
5 y5 years+151.1%-68.3%

AMRX Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+97.3%-65.7%+38.0%
5 y5-yearat high+151.1%-68.6%+46.9%
alltimeall timeat high+269.5%-68.6%+175.0%

AMRX Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$192.53M(-25.6%)
Dec 2024
$258.69M(+80.2%)
$258.69M(+10.1%)
Sep 2024
-
$235.00M(+17.7%)
Jun 2024
-
$199.58M(+13.8%)
Mar 2024
-
$175.32M(+22.1%)
Dec 2023
$143.57M(-13.5%)
$143.57M(-19.1%)
Sep 2023
-
$177.40M(+27.1%)
Jun 2023
-
$139.53M(-70.1%)
Mar 2023
-
$467.42M(+181.6%)
Dec 2022
$165.98M(+26.6%)
$165.98M(-68.8%)
Sep 2022
-
$531.46M(-5.4%)
Jun 2022
-
$561.69M(+4.1%)
Mar 2022
-
$539.73M(+311.7%)
Dec 2021
$131.08M
$131.08M(-77.8%)
DateAnnualQuarterly
Sep 2021
-
$589.41M(-1.1%)
Jun 2021
-
$596.23M(+3.8%)
Mar 2021
-
$574.32M(+275.0%)
Dec 2020
$153.14M(+48.6%)
$153.14M(-75.0%)
Sep 2020
-
$613.62M(+2.4%)
Jun 2020
-
$599.49M(-1.2%)
Mar 2020
-
$606.92M(+489.1%)
Dec 2019
$103.02M(-10.3%)
$103.02M(-79.2%)
Sep 2019
-
$495.86M(-1.8%)
Jun 2019
-
$505.14M(-9.6%)
Mar 2019
-
$558.75M(+386.5%)
Dec 2018
$114.85M(+64.0%)
$114.85M(-7.8%)
Sep 2018
-
$124.54M(-26.3%)
Jun 2018
-
$169.05M(+141.4%)
Dec 2017
$70.01M
$70.01M

FAQ

  • What is Amneal Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals annual accounts payable year-on-year change?
  • What is Amneal Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals quarterly accounts payable year-on-year change?

What is Amneal Pharmaceuticals annual accounts payable?

The current annual accounts payable of AMRX is $258.69M

What is the all time high annual accounts payable for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high annual accounts payable is $258.69M

What is Amneal Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, AMRX annual accounts payable has changed by +$115.12M (+80.18%)

What is Amneal Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of AMRX is $192.53M

What is the all time high quarterly accounts payable for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high quarterly accounts payable is $613.62M

What is Amneal Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, AMRX quarterly accounts payable has changed by +$17.21M (+9.81%)
On this page